178 related articles for article (PubMed ID: 1438188)
1. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
O'Neil KT; Hoess RH; Jackson SA; Ramachandran NS; Mousa SA; DeGrado WF
Proteins; 1992 Dec; 14(4):509-15. PubMed ID: 1438188
[TBL] [Abstract][Full Text] [Related]
2. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
3. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
Müller G; Gurrath M; Kessler H
J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
7. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
8. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
[TBL] [Abstract][Full Text] [Related]
9. A discrete sequence in a platelet integrin is involved in ligand recognition.
D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF
Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847
[TBL] [Abstract][Full Text] [Related]
10. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
[TBL] [Abstract][Full Text] [Related]
11. The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonist.
Bogusky MJ; Naylor AM; Mertzman ME; Pitzenberger SM; Nutt RF; Brady SF; Colton CD; Veber DF
Biopolymers; 1993 Aug; 33(8):1287-97. PubMed ID: 8364159
[TBL] [Abstract][Full Text] [Related]
12. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.
Scarborough RM; Naughton MA; Teng W; Rose JW; Phillips DR; Nannizzi L; Arfsten A; Campbell AM; Charo IF
J Biol Chem; 1993 Jan; 268(2):1066-73. PubMed ID: 8419315
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
14. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.
Peishoff CE; Ali FE; Bean JW; Calvo R; D'Ambrosio CA; Eggleston DS; Hwang SM; Kline TP; Koster PF; Nichols A
J Med Chem; 1992 Oct; 35(21):3962-9. PubMed ID: 1433203
[TBL] [Abstract][Full Text] [Related]
15. Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation.
Ali FE; Bennett DB; Calvo RR; Elliott JD; Hwang SM; Ku TW; Lago MA; Nichols AJ; Romoff TT; Shah DH
J Med Chem; 1994 Mar; 37(6):769-80. PubMed ID: 8145226
[TBL] [Abstract][Full Text] [Related]
16. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
Andronati SA; Karaseva TL; Krysko AA
Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
Yamada T; Uyeda A; Kidera A; Kikuchi M
Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
Dennis MS; Henzel WJ; Pitti RM; Lipari MT; Napier MA; Deisher TA; Bunting S; Lazarus RA
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2471-5. PubMed ID: 2320569
[TBL] [Abstract][Full Text] [Related]
19. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities.
Giebel LB; Cass RT; Milligan DL; Young DC; Arze R; Johnson CR
Biochemistry; 1995 Nov; 34(47):15430-5. PubMed ID: 7492543
[TBL] [Abstract][Full Text] [Related]
20. Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.
Bovy PR; Tjoeng FS; Rico JG; Rogers TE; Lindmark RJ; Zablocki JA; Garland RB; McMackins DE; Dayringer H; Tóth MV
Bioorg Med Chem; 1994 Sep; 2(9):881-95. PubMed ID: 7712124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
